Plant ID: NPO8372
Plant Latin Name: Picrasma quassioides
Taxonomy Genus: Picrasma
Taxonomy Family: Simaroubaceae
NCBI TaxonomyDB:
210334
Plant-of-the-World-Online:
813963-1
Anthelmintic; Antiviral; Bitter; Febrifuge; Hypotensive; Parasiticide; Stomachic; Tonic
South Africa; Nepal; India; China; Japan; Taiwan
TSHR; OPRD1; NMUR2; | |
ADRA2C; ADRA2A; | |
GAA; ACHE; | |
BLM; HSD17B10; ALOX15; POLB; | |
IKBKB; MAPK1; PIM1; KIT; CSNK2A1; | |
CA12; CA9; | |
ESR2; ESR1; | |
MAOB; | |
HIF1A; | |
LMNA; NPC1; RAB9A; | |
SMN1;SMN2; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Hydrolase | ACHE | Acetylcholinesterase | P22303 | CHEMBL220 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Nuclear hormone receptor subfamily 3 group A | ESR2 | Estrogen receptor beta | Q92731 | CHEMBL242 |
Nuclear hormone receptor subfamily 3 group A | ESR1 | Estrogen receptor alpha | P03372 | CHEMBL206 |
Oxidoreductase | MAOB | Monoamine oxidase B | P27338 | CHEMBL2039 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Peptide receptor (family A GPCR) | OPRD1 | Delta opioid receptor | P41143 | CHEMBL236 |
Peptide receptor (family A GPCR) | NMUR2 | Neuromedin-U receptor 2 | Q9GZQ4 | CHEMBL1075144 |
Protein Kinase | IKBKB | Inhibitor of nuclear factor kappa B kinase beta subunit | O14920 | CHEMBL1991 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Protein Kinase | PIM1 | Serine/threonine-protein kinase PIM1 | P11309 | CHEMBL2147 |
Protein Kinase | KIT | Stem cell growth factor receptor | P10721 | CHEMBL1936 |
Protein Kinase | CSNK2A1 | Casein kinase II alpha | P68400 | CHEMBL3629 |
Small molecule receptor (family A GPCR) | ADRA2C | Alpha-2c adrenergic receptor | P18825 | CHEMBL1916 |
Small molecule receptor (family A GPCR) | ADRA2A | Alpha-2a adrenergic receptor | P08913 | CHEMBL1867 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | NPC1 | Niemann-Pick C1 protein | O15118 | CHEMBL1293277 |
Unclassified | RAB9A | Ras-related protein Rab-9A | P51151 | CHEMBL1293294 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0032502; developmental process | GO:0048856; anatomical structure development | 2.594E-06 | 5.153E-03 | ACHE, ALOX15, CSNK2A1, ESR1, GAA, HIF1A, KIT, LMNA, MAOB, MAPK1, NMUR2, PIM1, POLB, SMN1, SMN2, TSHR |
BP | GO:0032501; multicellular organismal process | GO:0006940; regulation of smooth muscle contraction | 2.603E-06 | 5.153E-03 | ADRA2A, ADRA2C, KIT, NMUR2 |
MF | GO:0060089; molecular transducer activity | GO:0038052; RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | 2.176E-06 | 5.153E-03 | ESR1, ESR2 |
BP | GO:0009987; cellular process | GO:0007200; phospholipase C-activating G-protein coupled receptor signaling pathway | 8.366E-06 | 9.588E-03 | ADRA2A, ESR1, NMUR2, OPRD1 |
MF | GO:0060089; molecular transducer activity | GO:0004938; alpha2-adrenergic receptor activity | 6.523E-06 | 9.588E-03 | ADRA2A, ADRA2C |
MF | GO:0005488; binding | GO:0005496; steroid binding | 7.990E-06 | 9.588E-03 | CYP3A4, ESR1, ESR2, NPC1 |
BP | GO:0007610; behavior | GO:0007610; behavior | 1.173E-05 | 1.092E-02 | GAA, HIF1A, KIT, MAPK1, NMUR2, NPC1, OPRD1 |
BP | GO:0009987; cellular process | GO:0032811; negative regulation of epinephrine secretion | 1.303E-05 | 1.092E-02 | ADRA2A, ADRA2C |
MF | GO:0005488; binding | GO:0034056; estrogen response element binding | 1.303E-05 | 1.092E-02 | ESR1, ESR2 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 1.303E-05 | 1.092E-02 | CYP2C9, CYP3A4 |
CC | GO:0016020; membrane | GO:0005886; plasma membrane | 3.421E-05 | 1.576E-02 | ACHE, ADRA2A, ADRA2C, ALOX15, CA12, CA9, CSNK2A1, ESR1, GAA, HSD17B10, KIT, MAPK1, NMUR2, OPRD1, PIM1, RAB9A, TSHR |
CC | GO:0043226; organelle | GO:0097504; Gemini of coiled bodies | 1.423E-04 | 4.004E-02 | SMN1, SMN2 |
CC | GO:0032991; macromolecular complex | GO:0032797; SMN complex | 1.680E-04 | 4.285E-02 | SMN1, SMN2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09160 Human Diseases | 09161 Cancers | hsa05221 | Acute myeloid leukemia | 1.335E-06 | 1.896E-04 | IKBKB, KIT, PIM1, MAPK1 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 1.987E-05 | 9.403E-04 | CYP2C9, MAOB, ALOX15, MAPK1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 9.765E-06 | 6.933E-04 | CYP2C9, ALOX15, CYP3A4 |
09130 Environmental Information Processing | 09133 Signaling molecules and interaction | hsa04080 | Neuroactive ligand-receptor interaction | 4.446E-05 | 1.578E-03 | OPRD1, NMUR2, ADRA2C, ADRA2A, TSHR |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04150 | mTOR signaling pathway | 8.872E-05 | 2.239E-03 | IKBKB, MAPK1, HIF1A |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04022 | cGMP-PKG signaling pathway | 9.463E-05 | 2.239E-03 | OPRD1, MAPK1, ADRA2C, ADRA2A |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 1.234E-04 | 2.390E-03 | KIT, MAPK1, HIF1A |
09150 Organismal Systems | 09152 Endocrine system | hsa04917 | Prolactin signaling pathway | 1.528E-04 | 2.411E-03 | MAPK1, ESR1, ESR2 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.347E-04 | 2.390E-03 | CYP2C9, MAOB, CYP3A4 |
09150 Organismal Systems | 09152 Endocrine system | hsa04915 | Estrogen signaling pathway | 3.915E-04 | 5.054E-03 | MAPK1, ESR1, ESR2 |
09150 Organismal Systems | 09152 Endocrine system | hsa04919 | Thyroid hormone signaling pathway | 6.541E-04 | 7.740E-03 | MAPK1, ESR1, HIF1A |
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 2.724E-04 | 3.868E-03 | CA12, CA9 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
G00-G99: Diseases of the nervous system G00-G99 | Parkinson's disease | G20 | ACHE; |
H00-H59: Diseases of the eye and adnexa | Glaucoma | H40-H42 | ACHE; |
N00-N99: Diseases of the genitourinary system | Urinary dysfunction | N39.3-N39.4 | ACHE; |
C00-D49: Neoplasms | Breast cancer | C50 | CA9; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9; |
NA: NA | Upper abdominal bloating | NA | ACHE; |
K00-K95: Diseases of the digestive system | Xerostomia | K11.7, R68.2 | ACHE; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Poison intoxication | T36-T50 | ACHE; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Poisoning due to pesticides and chemicals | T36-T50 | ACHE; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Mild cognitive impairment | F06.7 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Neurodegenerative disease | G30-G32 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Epileptic seizures | G40, P90, R56 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Myasthenia gravis diagnosis | G70.0 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Myasthenia gravis | G70.0 | ACHE; |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9; |
NA: NA | Early satiation associated with functional dyspepsia | NA | ACHE; |
A00-B99: Certain infectious and parasitic diseases | Helminth infection | A00-B99 | ACHE; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | ACHE; |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9; |
A00-B99: Certain infectious and parasitic diseases | Pediculus humanus capitis | B85.0 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Pain | G64, G90.0, R52, G89 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | ACHE; |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | ACHE; |
H00-H59: Diseases of the eye and adnexa | Chronic glaucoma | H40-H42 | ACHE; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Anxiety disorder | F32, F40-F42 | ACHE; |
C00-D49: Neoplasms | Renal cancer | C64 | CA9; |
C00-D49: Neoplasms | Cancer | C00-C96 | ACHE; CA9; |